Price & volume screen · refreshed after the Nov 11, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 201 | DNLIDenali TherapeuticsHealthcare | $19.76 | +7.4% | −0.2% | −27.4% | $3.17B |
| 202 | PENPenumbraHealthcare | $321.81 | +0.6% | −0.2% | −10.5% | $12.68B |
| 203 | AUPHAurinia PharmaceuticalsHealthcare | $15.90 | −2.8% | −0.8% | −14.6% | $2.13B |
| 204 | CGONCG OncologyHealthcare | $73.36 | +17.6% | −0.9% | −9.1% | $6.55B |
| 205 | HROWHarrowHealthcare | $29.53 | +4.6% | −1.0% | −46.1% | $1.11B |
| 206 | GMEDGLOBUS MEDICALHealthcare | $74.80 | −2.0% | −1.0% | −22.7% | $9.92B |
| 207 | DYNDyne TherapeuticsHealthcare | $18.25 | +19.3% | −1.0% | −31.9% | $3.42B |
| 208 | KRYSKrystal BiotechHealthcare | $307.90 | −4.1% | −1.5% | −18.6% | $9.12B |
| 209 | LQDALiquidiaHealthcare | $56.44 | +110.5% | −2.0% | −38.0% | $5.09B |
| 210 | SVRASavaraHealthcare | $5.14 | +7.4% | −2.6% | −26.0% | $1.13B |
| 211 | ATECAlphatec HoldingsHealthcare | $7.36 | −32.0% | −2.6% | −67.6% | $1.13B |
| 212 | TRVITrevi TherapeuticsHealthcare | $14.83 | +20.6% | −2.9% | −24.0% | $2.11B |
| 213 | CLDXCelldex TherapeuticsHealthcare | $30.60 | +8.3% | −5.9% | −31.8% | $2.40B |
| 214 | SRRKScholar Rock HoldingHealthcare | $47.15 | +16.4% | −6.0% | −21.5% | $5.75B |
| 215 | XRAYDENTSPLY SIRONAHealthcare | $9.69 | +13.9% | −7.2% | −34.0% | $1.93B |
| 216 | VKTXViking TherapeuticsHealthcare | $28.87 | +8.3% | −8.9% | −31.5% | $3.68B |
| 217 | DVADaVitaHealthcare | $179.30 | −1.5% | −9.5% | −25.6% | $11.28B |
| 218 | SMMTSummit TherapeuticsHealthcare | $16.92 | +9.0% | −10.0% | −35.9% | $13.53B |
| 219 | PRCTPROCEPT BioRoboticsHealthcare | $23.03 | +20.6% | −10.4% | −36.2% | $1.33B |
| 220 | KLACKLAHealthcare | $163.41 | −11.2% | −11.7% | −45.8% | $212.92B |
| 221 | STAAStaar Surgical CoHealthcare | $25.93 | +20.6% | −11.8% | −22.2% | $1.30B |
| 222 | ANIPANI PharmaceuticalsHealthcare | $71.30 | +0.6% | −11.9% | −19.8% | $1.62B |
| 223 | PTCTPTC TherapeuticsHealthcare | $64.60 | +7.8% | −12.1% | −27.9% | $5.40B |
| 224 | SRPTSarepta Therapeutics,Healthcare | $16.56 | +0.3% | −12.1% | −30.5% | $1.78B |
| 225 | COGTCogent BiosciencesHealthcare | $30.02 | +6.9% | −12.5% | −29.9% | $5.22B |
| 226 | CRSPCRISPR Therapeutics AGHealthcare | $45.70 | −8.8% | −13.4% | −26.2% | $4.43B |
| 227 | SNDASonida Senior LivingHealthcare | $33.52 | −6.9% | −13.6% | −22.2% | $1.65B |
| 228 | IMNMImmunomeHealthcare | $19.08 | +8.5% | −14.1% | −36.0% | $2.25B |
| 229 | MIRMMirum PharmaceuticalsHealthcare | $93.78 | +17.8% | −14.1% | −27.1% | $6.12B |
| 230 | STOKStoke TherapeuticsHealthcare | $27.20 | +20.9% | −14.2% | −29.1% | $1.78B |
| 231 | BSXBoston ScientificHealthcare | $45.40 | +4.8% | −14.4% | −56.8% | $65.80B |
| 232 | PBHPrestige Consumer HealthcareHealthcare | $43.93 | −9.4% | −15.2% | −37.4% | $2.08B |
| 233 | HIMSHims & Hers HealthHealthcare | $20.45 | −31.2% | −15.3% | −50.2% | $4.79B |
| 234 | URGNUroGen PharmaHealthcare | $26.05 | −31.9% | −15.8% | −48.2% | $1.28B |
| 235 | MDGLMadrigal PharmaceuticalsHealthcare | $435.06 | −3.8% | −16.2% | −27.8% | $10.11B |
| 236 | ACADAcadia PharmaceuticalsHealthcare | $18.45 | −0.9% | −16.8% | −39.6% | $3.19B |
| 237 | QUREuniQureHealthcare | $23.75 | +11.6% | −18.6% | −53.5% | $1.67B |
| 238 | IBRXImmunityBioHealthcare | $6.64 | −32.3% | −18.6% | −42.6% | $7.06B |
| 239 | INVAInnovivaHealthcare | $18.81 | −9.3% | −18.7% | −22.4% | $1.34B |
| 240 | BEAMBeam TherapeuticsHealthcare | $25.75 | +5.4% | −19.2% | −32.1% | $2.67B |
| 241 | LMATLeMaitre VascularHealthcare | $78.97 | −3.2% | −19.6% | −32.7% | $1.81B |
| 242 | NTLAIntellia TherapeuticsHealthcare | $11.46 | −3.8% | −19.8% | −35.8% | $1.61B |
| 243 | BCRXBioCryst PharmaceuticalsHealthcare | $7.67 | −5.0% | −20.1% | −31.0% | $1.97B |
| 244 | ANABAnaptysBioHealthcare | $48.57 | +6.5% | −22.5% | −30.8% | $1.45B |
| 245 | VERAVera TherapeuticsHealthcare | $30.30 | +13.1% | −22.6% | −45.6% | $2.19B |
| 246 | IRTCiRhythm HoldingsHealthcare | $88.33 | −18.0% | −23.0% | −53.3% | $2.93B |
| 247 | INBXInhibrx BiosciencesHealthcare | $90.31 | +3.7% | −23.4% | −36.3% | $1.33B |
| 248 | CYTKCytokineticsHealthcare | $58.83 | −4.5% | −23.8% | −32.6% | $8.20B |
| 249 | BFAMBRIGHT HORIZONS FAMILY SOLUTIONSHealthcare | $51.44 | −24.5% | −25.0% | −50.8% | $2.47B |
| 250 | RCUSArcus BiosciencesHealthcare | $18.71 | −16.9% | −25.2% | −40.7% | $2.69B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.